Results 61 to 70 of about 3,268,533 (214)
Direct healthcare costs of diabetes mellitus patients in Spain [PDF]
, 2003 Objectives. To estimate the healthcare resources spent by diabetic patients in Spain during the year 2002. Methods. The present work is a cost-of-illness study.
Lobo, Félix +3 more
core +3 more sources
The Pharmacological Potential of Mushrooms [PDF]
, 2005 This review describes pharmacologically active compounds from mushrooms. Compounds and complex substances with antimicrobial, antiviral, antitumor, antiallergic, immunomodulating, anti-inflammatory, antiatherogenic, hypoglycemic, hepatoprotective and ...
Jülich, Wolf-Dieter +2 more
core +3 more sources
Journal of Diabetes Investigation, 2017 To compare the treatment satisfaction of four classes of oral hypoglycemic agents (OHAs): dipeptidyl peptidase‐4 (DPP‐4) inhibitors, α‐glucosidase inhibitors (αGI), biguanides (BG) and sulfonylureas (SU), which are common initial treatments for type 2 ...
H. Ishii +4 more
semanticscholar +1 more source
, 2017 Introduction : Oral hypoglycemic agents (OHAs) are the most common drugs used in Type 2 Diabetes Mellitus. There are various established adverse effects related to their use including hypoglycemia, weight gain, gastrointestinal disturbance, lactic ...
J. Shrestha +4 more
semanticscholar +1 more source
EFFECT OF CHLOROQUINE ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS [PDF]
Acta Medica Iranica, 1998 77irty six patients with non insulin dependent diabetes mellitus, whose blood sugar was not controlled with maximal doses of oral hypoglycemic agents and did not accept insulin treatment, were selected for this study.
H. Mostafavi
doaj +1 more source
Natural products for the treatment of Type 2 Diabetes Mellitus [PDF]
, 2015 Type 2 diabetes mellitus is a metabolic disease characterized by persistent hyperglycemia. High blood sugar can produce long-term complications such as cardiovascular and renal disorders, retinopathy, and poor blood flow. Its development can be prevented
Barrios, José Luis +2 more
core +2 more sources
Vildagliptin and its role in the treatment of diabetes mellitus
Сахарный диабет, 2010 Type 2 diabetes mellitus is a most serious medical problem throughout the world. Traditional hypoglycemic agents do not ensure long-term control ofglycemia and fail to affect the natural course of DM.
Yury Shavkatovich Khalimov
doaj +1 more source
How Disease Burden Influences Medication Patterns for Medicare Beneficiaries: Implications for Policy [PDF]
, 2008 Provides benchmarks for assessing the quality of pharmaceutical care under the Medicare Part D prescription drug benefit. Examines how the beneficiaries?
Bruce C. Stuart
core
miRNAs as Regulators of Antidiabetic Effects of Fucoidans [PDF]
, 2019 open access articleDiabetes mellitus is a metabolic disease with a high mortality rate worldwide. MicroRNAs (miRNAs), and other small noncoding RNAs, serve as endogenous gene regulators through binding to specific sequences in RNA and modifying gene ...
Arroo, R. R. J. +8 more
core +1 more source
Рациональная фармакотерапия в кардиологии, 2016 The classic hypoglycemic agents include biguanides, sulfonylurea drugs, meglitinides, glitazones and alpha-glucosidase inhibitors. Modern algorithm of hypoglycemic therapy in the first step considers lifestyle modification and metformin monotherapy, the ...
A. A. Aleksandrov
doaj +1 more source